Skip to content

Debt-to-assets at other companies

Eli Lilly logo
Eli LillyLLY
0.4×-0.1×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.3×0.0×
Amgen logo
AmgenAMGN
0.6×0.0×
AbbVie logo
AbbVieABBV
0.5×0.0×
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
0.0×
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
0.0×

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Calculated from Shattuck Labs, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s debt-to-assets?
Shattuck Labs, Inc. (STTK) reported debt-to-assets of 0× in Q1 2026.
How has Shattuck Labs, Inc.'s debt-to-assets changed year-over-year?
Shattuck Labs, Inc.'s debt-to-assets decreased by 31.6% year-over-year, from 0× to 0×.
What is the long-term trend for Shattuck Labs, Inc.'s debt-to-assets?
Over 4 years (2020 to 2025), Shattuck Labs, Inc.'s debt-to-assets has grown at a 38.2% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.